Daria V. Babushok, MD, PHD

Sande CM, Chen S, Mitchell DV, Lin P, Abraham DM, Cheng J, Gebhard T, Deolikar RJ, Freeman C, Zhou M, Kumar S, Bowman M, Bowman RL, Zheng S, Munkhbileg B, Chen Q, Stanley NL, Guo K, Lapite A, Hausler R, Taylor DM, Corines J, Morrissette JJD, Lieberman DB, Yang G, Shestova O, Gill S, Zheng J, Simmer KS, Banaszak LG, Shoger K, Reinig EF, Peterson M, Nicholas P, Walne AJ, Dokal I, Rosenheck JP, Oetjen KA, Link DC, Gelman AE, Reilly CR, Dutta R, Lindsley RC, Brundige K, Agarwal S, Bertuch AA, Churpek JE, Tague LK, Johnson FB, Olson TS, Babushok DV. ATM-dependent DNA damage response constrains cell growth and drives clonal hematopoiesis in telomere biology disorders. , J Clin Invest, 135(8): 2025,e181659.

Höchsmann B, Gerber GF, Leopold W, Patel BJ, Gavriilaki E, Hefter A, Kalhammer U, Opitz SA, Marx-Hoffmann A, Knight DB, Brodsky RA, Marvaki A, Lalayanni C, Körper S, Babushok DV, Schrezenmeier H. Ravulizumab for Treatment of Paroxysmal Nocturnal Hemoglobinuria During Pregnancy , Blood Adv, 29: 2026

Brown TJ, Barrett N, Meng H, Ricciotti E, McDonnell C, Dancis A, Qualtieri J, FitzGerald GA, Cotter M, Babushok DV. Nonsteroidal anti-inflammatory drugs as a targeted therapy for bone marrow failure in Ghosal hematodiaphyseal dysplasia. , Blood, 141(13): 2023,1553-1559.

Connor MP, Prathapa N, Frey NV, Gill SI, Hexner EO, Bruno XJ, Lai CE, Loren AW, Luger SM, Matthews AH, McCurdy SR, Perl AE, Porter DL, Zeringue A, Oved JH, Olson TS, Pratz KW, Babushok DV. Hypomethylating agents are associated with high rates of hematologic toxicity in patients with secondary myeloid neoplasms developing after acquired aplastic anemia , Haematologica, 109(8): 2024,2732-2737.

Colden M, Kumar S, Munkhbileg B, Babushok DV Insights into the emergence of paroxysmal nocturnal hemoglobinuria. , Front Immunol., 12: 2022,830172

Olson TS, Frost BF, Duke JL, Dribus M, Xie HM, Prudowsky ZD, Furutani E, Gudera J, Shah YB, Ferriola D, Dinou A, Pagkrati I, Kim S, Xu Y, He M, Zheng S, Nijim S, Lin P, Xu C, Nakano T, Oved JH, Carreno BM, Bolon YT, Gadalla SM, Marsh SG, Paczesny S, Lee SJ, Monos DS, Shimamura A, Bertuch AA, Gragert L, Spellman S, Babushok DV Pathogenicity and impact of HLA class I alleles in aplastic anemia patients of different ethnicities , JCI Insight, 11(22): 2022,e163040

Shah YB, Priore SF, Li Y, Tang CN, Nicholas P, Kurre P, Olson TS, Babushok DV. The predictive value of PNH clones, 6p CN-LOH, and clonal TCR gene rearrangement for aplastic anemia diagnosis. , Blood Adv. , 5(16): 2021,3216-3226

Babushok DV, Duke JL, Xie HM, Stanley N, Atienza J, Perdigones, N, Nicholas P, Ferriola D, Li Y, Huang H, Ye W, Morrissette J, Podsakoff G, Biegel JA, Chou S, Monos DS, Bessler M, Olson TS. Somatic HLA Mutations Expose the Role of Class I-Mediated Autoimmunity in Aplastic Anemia and its Clonal Complications. , Blood Adv, 1(22): 2017,1900-1910

Babushok Daria V, Perdigones Nieves, Perin Juan C, Olson Timothy S, Ye Wenda, Roth Jacquelyn J, Lind Curt, Cattier Carine, Li Yimei, Hartung Helge, Paessler Michele E, Frank Dale M, Xie Hongbo M, Cross Shanna, Cockroft Joshua D, Podsakoff Gregory M, Monos Dimitrios, Biegel Jaclyn A, Mason Philip J, Bessler Monica Emergence of clonal hematopoiesis in the majority of patients with acquired aplastic anemia. , Cancer Genetics, 208(4): 2015,115-28